Stay updated on Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows a new revision label, Revision: v3.5.4, replacing the previous v3.5.3, indicating an internal update to the page version without changing publicly visible study information.
    Difference
    0.0%
    Check dated 2026-05-14T23:13:08.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.5.3 was added, replacing the previous v3.5.2. This reflects a small internal update to the page template rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-04-30T17:15:42.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T09:35:30.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:22:06.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T15:25:12.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.4.2' was added, and the page no longer displays the previous government-funding notice or the earlier 'Revision: v3.4.1' text. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:06:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.